4//SEC Filing
Akinsanya Karen 4
Accession 0001490978-23-000011
CIK 0001490978other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:59 PM ET
Size
5.4 KB
Accession
0001490978-23-000011
Insider Transaction Report
Form 4
Akinsanya Karen
President of R&D, Therapeutics
Transactions
- Award
Stock Option (right to buy)
2023-02-09+63,270→ 63,270 totalExercise: $23.29Exp: 2033-02-09→ Common Stock (63,270 underlying)
Footnotes (1)
- [F1]The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.
Documents
Issuer
Schrodinger, Inc.
CIK 0001490978
Entity typeother
Related Parties
1- filerCIK 0001797672
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:59 PM ET
- Size
- 5.4 KB